Hologic (NSDQ:HOLX) CEO Steven MacMillan offered a glowing review to major stakeholder Carl Icahn, saying that activist investor is “not into our shorts at all.”
MacMillan joined Hologic late last year amid something of a tremulous time, with activist investor Icahn nabbing up more than 12.6% of the company and demanding changes.
Hologic agreed to take on 2 new board nominees and made other changes in order to appease Icahn, but MacMillan maintained that the influence has done wonders for the company.
Help employers find you! Check out all the jobs and post your resume.
